Nanoparticles Point the Way to Stem Cells for MRI
Iron-laden nanoparticles make non-toxic stem cell labels for magnetic resonance imaging. Imaging agents are used to enhance the resolution in magnetic resonance imaging (MRI), which allows internal structure of the body to be visualised. Xiaoyuan Chen at the National Institute of Health, Bethesda, has modified iron-oxide nanoparticles to make non-toxic and more efficient imaging agents.
Iron oxide has been used for cell labelling before but transfection agents are needed to aid uptake into cells. This can make them toxic and result in cell death, particularly in sensitive cell lines such as stem cells, explains Chen. Chen coated his iron oxide nanoparticles with a biologically compatible agent (human serum albium) and found that they could enter a variety of cells without adding external transfection agents and with no adverse effects on cell growth.
'There's a massive incentive to label cells, such as stem cells, efficiently', says Chen as there are notorious difficulties surrounding stem cell tagging in an efficient and non-toxic manner, he explains. But with his method, he claims that the cell labelling was more efficient than the commercially available imaging agent, Feridex.
Chen used his nanoparticles to label a cell line that tracks specifically to areas of inflammation in the body, such as the brain in a stroke victim, or to tumours during their growth period. When the iron-tagged cells were injected to a mouse that had a tumour under the skin, they could be detected at the tumour site after just 6 hours using MRI - proving that the nanoparticles can be used as an efficient and non-invasive diagnostic tool.
'The main advance is a non-toxic imaging agent that has been specifically designed for cell entry', comments Kevin Dhaliwal, an expert in MRI and imaging agents from the Medical Research Council Centre for Inflammation Research, Edinburgh, UK. 'The particles could be widely applied in clinical applications,' continues Dhaliwal.
Chen indicates that future research may focus on coupling drugs to the nanoparticles to provide a site-specific drug delivery vehicle.
Source: RSC Publishing /...
The Institute of Nanotechnology puts significant effort into ensuring that the information provided on its news pages is accurate and up-to-date. However, we cannot guarantee absolute accuracy. Consequently, the Institute of Nanotechnology disclaims any and all responsibility for inaccuracy, omission or any kind of deficiency in relation to the news items and articles hosted herein.
- 04 March 2014NanoCelluComp presents final results at JEC Europe 2014
- 17 February 2014Researchers Hijack Cancer Migration Mechanism to “Move” Brain Tumours
- 12 February 2014Fingerprinting meningitis with lasers
- 06 February 2014European Innovation Convention 2014
- 30 January 2014NanoSafety Cluster Newsletter No.2 - Out Now
- View All